Arcus Biosciences RCUS
NYSE RCUS
$26.14 +0.49 (+1.91%)
As of: Sep 30, 2026 · 11:29 AM EDT

Arcus Biosciences (RCUS) Total Non-Current Liabilities (2017 - 2026)

Updated

Arcus Biosciences (RCUS) reported Total Non-Current Liabilities of $336 million for Q2 2026, down 8.4% from $367 million a year earlier and down 5.1% from the prior quarter.

Analysis

Arcus Biosciences (RCUS) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Arcus Biosciences posted Total Non-Current Liabilities of $373 million, down 26.6% from FY2024.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of 6.7% (FY2020 to FY2025).
  • By year, Total Non-Current Liabilities came in at $508 million in FY2024 (+3.5%), $491 million in FY2023 (-10.4%), $548 million in FY2022 (-12.7%) and $628 million in FY2021 (+132.8%).
  • The Q2 2026 figure ranks as the lowest quarterly Total Non-Current Liabilities since Q3 2021.
  • Year over year, Total Non-Current Liabilities has now declined in each of the last five quarters, with an average decline of 11.0% over the last eight quarters.
  • The high point for year-over-year Total Non-Current Liabilities in five years was Q1 2022 (growth of 181.6%); the low point was Q1 2023 (a decline of 30.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $354 million (Q1 2026), $373 million (Q4 2025) and $386 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Arcus Biosciences 3.18 Bn -157.19 Mn - 336.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 336.00 Mn
Mar 31, 2026 354.00 Mn
Dec 31, 2025 373.00 Mn
Sep 30, 2025 386.00 Mn
Jun 30, 2025 367.00 Mn
Mar 31, 2025 459.00 Mn
Dec 31, 2024 508.00 Mn
Sep 30, 2024 551.00 Mn
Jun 30, 2024 413.00 Mn
Mar 31, 2024 446.00 Mn
Dec 31, 2023 491.00 Mn
Sep 30, 2023 526.00 Mn
Jun 30, 2023 510.00 Mn
Mar 31, 2023 509.00 Mn
Dec 31, 2022 548.00 Mn
Sep 30, 2022 678.66 Mn
Jun 30, 2022 715.09 Mn
Mar 31, 2022 732.55 Mn
Dec 31, 2021 628.00 Mn
Sep 30, 2021 286.48 Mn
API Access

Arcus Biosciences Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RCUS&period=max&api_key=YOUR_API_KEY